COSTS OF MEDICARE COVERING NEW OBESITY DRUGS COULD BE COSTLY

March 11 (Reuters) - The cost of expanding U.S. Medicare prescription drug coverage to pay for expensive, new obesity medications could be catastrophic, health economists warned in a report published on Saturday.

Learn More